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Abstract 
Native protein kinase C_~ from porcine spleen is phosphorylated in vitro by the tyrosine kinase src and to a much smaller extent by fyn. The tyrosine 
phosphorylation f PKC~ is restricted to the activated state of the enzyme, i.e. it occurs only in the presence of an activator, such as TPA or bryostatin. 
Upon phosphorylation at tyrosine, the apparent molecular weight of PKC~ increases by 6 kDa. Phosphorylation by src induces a stimulation of PKC~ 
activity apparently exhibiting some substrate selectivity. Other PKC isoenzymes, uch as cPKC (g~,7), are not phosphorylated by src or only to 
a very small extent. This phosphorylation is not dependent on TPA and does not cause an increase in activity and molecular weight of the enzyme. 
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1. Introduction 
The PKC family, a group of 10 isoenzymes known so 
far with phospholipid-dependent serine/threonine kinase 
activity, plays a key role in signal transduction and is 
involved in the regulation of numerous cellular processes 
and probably in tumor promotion (for reviews ee [1-4]). 
Over-expression of various PKCs in different cell lines 
has indicated that a certain isoenzyme might induce a 
specific effect, such as increased or reduced cell prolifer- 
ation [5-10]. However, distinct functions of the different 
isoenzymes in signaling processes, especially with respect 
to selective phosphorylation f substrates, are unknown 
to date. 
PKC_~ was purified to homogeneity from porcine 
spleen [11]. It is a member of the Ca2+-unresponsive, 
diacylglycerol (or TPA)-activatable subgroup of PKC 
isoenzymes, termed nPKC. Preliminary results indicate 
some substrate specificity of PKC~ as compared to Ca 2÷- 
responsive isoenzymes (cPKC). In order to investigate 
whether PKC, and especially its substrate specificity, 
might possibly be affected by events taking place in other 
signaling pathways, we studied the effect of tyrosine ki- 
nases on PKC~ and cPKC. Interactions of tyrosine and 
serine/threonine kinases in signaling cascades are well 
known. The most intriguing example recently studied in 
great detail is provided by the tyrosine kinase ~ ras 
* Corresponding author. 
Abbreviations: PKC, protein kinase C; TPA, 12-O-tetradeeanoylphor- 
bol-I 3-acetate; PS, phospatidyl serine; MAP-kinase, mitogen activated 
protein kinase; GAP, GTPase activating protein. 
raf ~ MAP-kinase cascade [12-14], in which PKC, pos- 
sibly via GAP [15-17], might also be involved. 
Here we show that purified PKCd~ is phosphorylated 
and stimulated rather specifically by src in vitro. Tyro- 
sine phosphorylation fPKC~ is dependent on the pres- 
ence of a PKC activator (e.g. TPA or bryostatin), i.e. on 
the activated state of the enzyme. Tyrosine phosphoryla- 
tion of PKC_~ appears to modulate the substrate specific- 
ity of the kinase. 
2. Materials and methods 
2.1. Materials 
TPA, bryostatin and G66983 were kindly provided by Dr. E. Hecker, 
German Cancer Research Center, Heidelberg, Dr. G.R. Pettit, State 
University of Arizona, Tempe, USA, and Gtdecke AG, Freiburg, Ger- 
many, respectively. [~'32p]ATP (sp¢~. act. 3,000 Ci/mmol) was from 
DuPont-New England Nuclear (Waltham, MA, USA). Phosphatidyl 
serine (PS) and myelin basic protein were from Sigma, Munich, and 
protamine sulfate from Serva, Heidelberg, Germany. The anti- 
phosphotyrosine antibody was from Gibeo BRL. Phosphotyrosine 
phosphatase-lB and src were from Upstate Biotechnology Inc., Lake 
Placid. In one experiment (see Fig. 1) preparations of src and fyn were 
used that were a generous gift of Dr. S.A. Courtneidge, EMBL, Hei- 
delberg. The catalytic subunit of the EGF receptor was generously 
provided by Dr. D. Fabbro, Ciba Geigy, Basel. The pseudosubstrate- 
related peptides ~ and 6 were synthesized by R. Pipkom, German 
Cancer Research Center, Heidelberg, and had the following sequences: 
RFARKGSLRQKNV (~t), MNRRGSIKQAKI (o'). 
2.2. Purification of PKC 
cPKC (a mixture of PKCa~,},) was purified from mouse brain [18] 
and PKC8 from porcine spleen [11] as described previously. 
2.3. Tyrosine phosphorylation of PKC 
cPKC or PKC5 was incubated with src or fyn and ATP (17 nM 
[32P]ATP + 30/zM ATP) at 30"C for 15 rain. The reaction mixture 
(total volume of 100/zl) contained: 50/zl of Tds-buffer (20 mM Tris- 
HC1, pH 7.5, 10 mM fl-mercaptoethanol), 4 mM MgCI2, 0.1 mM 
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MnSO4. Where indicated, 10/zg phosphatidyl serine (PS) and/or 10 -7 
M TPA were added. The reaction was stopped by the addition of 10% 
trichloroacetie acid, and the redissolved proteins were separated by 
SDS-PAGE. Tyrosin-phosphorylated proteins were visualized by im- 
munoblotting with an anti-phosphotyrosine antibody (see [17]). 
3. Results  and discussion 
PKCJ  purified to homogeneity from porcine spleen 
[11] could be phosphorylated at tyrosine residue(s) by the 
tyrosine kinase src in vitro as shown by immunoblot  
analysis with an anti-phosphotyrosine antibody (Fig. la 
and b). Tyrosine phosphorylat ion of  PKC J  was ob- 
served only in the presence of  the phorbol  ester TPA, i.e. 
in the activated state, but not in the absence of  all cofac- 
tors and not in the presence of  PS alone (Fig. la). Bry- 
ostatin, like TPA, was able to generate this activated 
form of  the enzyme and to allow its tyrosine phosphoryl-  
ation by src (data not shown). Tyrosine phosphorylat ion 
of  PKC J  with fyn, another kinase of  the src family, was 
much less effective than with src (Fig. lb), even though 
both kinase preparations exhibited equal activities with 
respect to the phosphorylat ion of  enolase. Preliminary 
results showed that the catalytic subunit of  the EGF  
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Fig. 1. Tyrosine phosphorylation of PKC~. 0.26/zg of PKCJ from porcine spleen [11] were incubated with 15 ng ofsrc from Upstate Biotechnology 
Inc. (a,c) or 6 and 15 ng ofsrc or fyn provided by Dr. S.A. Courtneidge (b,d), as described inSection 2. The latter preparations fsrc and fyn exhibited 
equal activities with respect to the phosphorylation of enolase. Tyrosine-phosphorylated proteins were visualized by immunoblotting with an 
anti-phosphotyrosine antibody (a,b), and total phosphorylated proteins by autoradiography (c,d). 
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receptor was barely, if at all, able to phosphorylate 
PKCd. This indicated some s lectivity towards the tyro- 
sine kinase. The tyrosine phosphorylation of PKCA 
caused an increase in its apparent molecular weight of 
around 6 kDa. In the absence of src PKCA was just 
autophosphorylated an  appeared as a 76 kDa protein 
(see also [11]) in the autoradiogram, whereas in the pres- 
ence of src PKCA became tyrosine-phosphorylated in 
addition to its autophosphorylation, exhibiting an ap- 
parent molecular weight of 82 kDa (Figs. lc and 2a). 
Incorporation of phosphate in addition to that incorpo- 
rated by autophosphorylation of PKC8 became vident 
also by the increase in radioactivity of PKCA 
phosphorylated in the presence of src over that in the 
absence of src (4,615 cpm vs. 2,517 cpm; see Fig. 2a). 
Tyrosine-phosphorylated PKCJ appeared in the im- 
munoblot (Figs. la and 2b) at the same location (82 kDa) 
as in the autoradiogram (Figs. lc and 2a). The molecular 
weight shift could be reversed by treatment of the tyro- 
sine-phosphorylated PKCJ with phosphotyrosine phos- 
phatase-1B (data not shown). The portion of PKCA that 
became tyrosine-phosphorylated (s e the band shift) was 
dependent on the amount of src in the assay. With the 
larger amount of src (15 rig) almost all PKCJ molecules 
appeared to be tyrosine-phosphorylated since just a faint 
band was visible at 76 kDa (Fig. ld). In contrast, the 
same amount of fyn caused just a small portion of the 
76 kDa band to shift to 82 kDa (Fig. l d). This is in 
accordance with the poor tyrosine phosphorylation f
PKC8 by fyn that we could demonstrate by immunoblot- 
ring with an anti-phosphotyrosine a tibody (see above, 
Fig. lb). Preliminary results with PKCJ fragments ob- 
tained after limited digestion with trypsin indicated hat 
the phosphorylated tyrosine residue(s) might be located 
downstream of the pseudosubstrate sequence RRGAIK. 
In this region only the tyrosine residues 155, 311,332, 
372, 446 and 628 (amino acid sequence of murine PKCA, 
see [18]) are PKC8-specific (not present in amino acid 
sequences of other PKC isoenzymes) and conserved in 
murine [19], rat [20] and human [21] PKCA. Inhibition 
of PKC activity, and thus also of autophosphorylation, 
by means of a highly specific PKC inhibitor (the stauro- 
sporine-related compound G66983, see [22]) did not af- 
PKC8 - 
src 
cpm 
2517 4615 
src + + + + 
G66983 - + 
Auto- Immuno- Immuno- 
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Fig. 2. Tyrosine phosphorylation of PKC_J in addition to its auto- 
phosphorylation: independence of PKC activity. Phosphorylation i  
the presence of PS/TPA was performed and proteins were visualized by 
autoradiography (a) and immunoblotting (b,c) as in Fig. 1. (a) The 
radioactivity ineach PKC2; band cut out of the blot was determined by 
scintillation counting and is given on top of the figure. (c) Phosphoryl- 
ation of PKCJ with src was performed in the absence (-) or presence 
(+) of the PKC inhibitor G66983 (1 gM). 
feet tyrosine phosphorylation f PKCJ (Fig. 2c). This 
finding indicates that it was not the TPA-induced stimu- 
lation of the activity and autophosphorylation of the 
enzyme but rather a conformational change of the kinase 
occurring concomitantly with its activation that might be 
an essential prerequisite of tyrosine phosphorylation. 
This special feature points to some physiological signifi- 
cance of the tyrosine phosphorylation f PKCJ. 
A specific physiological role of this phosphorylation 
was further indicated by our finding that incubation with 
src caused an increase in the activity of PKCJ (Table 1). 
but not of cPKC (PKC~,y  purified from mouse brain, 
see [18], data not shown). Again, this effect was observed 
only in the presence of TPA. Intriguingly, the increase 
in kinase activity proved to be dependent on the PKC 
Table 1 
Kinase activity of PKCJ and tyrosine-phosphorylated PKCJ (PKCt~(Tyr-P)) as determined with various substrates 
Substrate PKC8 PKC~(Tyr-P) Increase 
activity (clam) activity (cpm) (%) 
Myelin basic protein 
Histone-IIIS 
Pseudosubstrate-related peptide t~ 
Pseudosubstrate-related peptide ct 
Protamine sulfate 
71,608 _+ 2867 147,975 -+ 8880 107 
14,936 __ 750 26,832 -+ 2055 80 
230,080 __ 11504 320,326 _+ 14713 39 
104,027 -+ 7807 84,033 _+ 6954 0 (-19) 
213,917 _+ 17253 203,478 _+ 11274 0 (-5) 
PKCJ was phosphorylated with src in the presence of PSflTA as described in the legend to Fig. I. The activity of PKC2; and PKC~(Tyr-P) was 
determined with various substratcs in the presence of 10 ~/g PS and 10 -7 M TPA as described previously [27]. The values are the mean of two 
experiments. 
88 M. Gschwendt et al./ FEBS Letters 347 (1994) 85-89 
cPKC - 
cpm 
2093 2037 
src + + + + 
PS/ PS/ PS/ PS PS/ 
TPA TPA TPA TPA 
Autoradiogram Immunoblot 
Fig. 3. Phosphorylation f cPKC with src. ePKC (PKCa~8,7' purified 
from murine brain [18]) was incubated with src and [32p]ATP as de- 
scribed for PKC_~ in the legend to Fig. 1. Phosphorylated proteins were 
visualized either by autoradiography (a) or immunoblotting (b) and the 
radioactivity ineach cPKC band (see top of the figure) was determined 
as described in Fig. 2. 
substrate used for the assay (Table 1). Incorporation of 
phosphate into myelin basic protein was stimulated by 
107%, into histone by 80%, and into the pseudosub- 
strate-related pepdie ~ by 39%. No stimulation of kinase 
activity was observed with protamine sulfate and the 
pseudosubstrate-related peptide ** as substrates. Phos- 
phorylation of the substrate proteins was entirely due to 
PKC8, since src was not able to phosphorylate any of 
these substrates (data not shown). It is conceivable that 
specific substrates xist in cells which are phosphorylated 
exclusively or at least much more effectively by the tyro- 
sine-phosphorylated PKCt~. Very recently, when this 
paper was in preparation, tyrosine phosphorylation of
PKCt5 in response to treatment of PKCt%over-expressing 
cells with TPA [23] or to transfection of cells with ras m 
[24] was reported. Our finding of a stimulatory effect of 
tyrosine phosphorylation on the activity of PKC~ is in 
agreement with the first, but in contrast to the latter 
report, which describes an inhibition of kinase activity 
upon tyrosine phosphorylation. 
Tyrosine phosphorylation appeared to be rather spe- 
cific for the 8-isoenzyme, since incubation with src did 
not cause any incorporation of phosphate into cPKC 
exceeding that caused by autophosphorylation (see Fig. 
3a and compare with Fig. 2a). Nevertheless, weak tyro- 
sine phosphorylation of cPKC might have occurred as 
indicated by the immunoblot (Fig. 3b). However, it did 
not cause an increase in either molecular weight or en- 
zyme activity (see above) and was not dependent on 
TPA. Preliminary results with recombinant PKC isoen- 
zymes from baculovirus-infected insect cells indicate that 
some isoenzymes other than PKCS, such as PKC~', 
might also become tyrosine-phosphorylated by src to a 
very small extent. Again, however, phosphorylation of
these isoenzymes was not dependent on TPA and no 
increase in molecular weight was observed. Thus, the 
tyrosine phosphorylation of PKC5 differs clearly from 
that of other PKC isoenzymes and may have a specific 
quality. In intact cells, besides PKC$ no other PKC 
isoenzyme was found to be tyrosine-phosphorylated 
[23,24], indicating that the weak tyrosine phosphoryla- 
tion of other PKC isoenzymes een in vitro does not 
occur in vivo and thus might be physiologically irrele- 
vant. 
According to ur results, tyrosine phosphorylation of 
PKCt~ specifically causing an increase in its molecular 
weight is restricted to the activated form of the enzyme. 
Thus, tyrosine phosphorylation of PKCJ in vitro and 
upon treatment of cells with TPA appears to be due to 
the exposure of some tyrosine residue(s) as a conse- 
quence of TPA activation of PKCt~. However, we cannot 
exclude the possibility that TPA treatment of intact cells 
additionally causes activation of tyrosine kinases, such 
as src. It is tempting to speculate that, by means of the 
specific tyrosine phosphorylation of PKCZ and its acti- 
vation for selective substrate phosphorylation, an inter- 
action between PKC-mediated and tyrosine kinase-de- 
pendent signaling pathways is achieved. Tyrosine ki- 
nases of the src family are known to bind to growth 
factor and cytokine receptors and to be part of so-called 
signal transduction complexes together with other sig- 
naling molecules, e.g. for instance ras, raf and rasGAP 
(for reviews see [25,26]). Recently we have shown that 
rasGAP forms a complex with and is phosphorylated by
PKC [17]. Thus, via such signal transduction complexes 
PKC might get in contact with tyrosine kinase-depend- 
ent signaling pathways. 
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